Global Information
회사소개 | 문의 | 위시리스트

미국의 자가면역질환 진단 시장 기회(2020년)

United States Autoimmune Disorders Diagnostics Market Opportunities, 2020

리서치사 Pharmaion
발행일 2015년 12월 상품 코드 346827
페이지 정보 영문 89 Pages
가격
US $ 3,000 ₩ 3,551,000 Unprintable PDF by E-mail (Single User License)
US $ 3,500 ₩ 4,143,000 Printable PDF by E-mail (Single User License)
US $ 5,000 ₩ 5,919,000 PDF by E-mail (Enterprise License)


미국의 자가면역질환 진단 시장 기회(2020년) United States Autoimmune Disorders Diagnostics Market Opportunities, 2020
발행일 : 2015년 12월 페이지 정보 : 영문 89 Pages

의료비 증가, 자가면역질환 진단에 대한 대한 급속한 수요 증가, 진행중인 다양한 기술 진보로 인해 혁신적인 진단 절차가 등장하게 되면서 미국의 자가면역질환 진단 시장은 향후에도 확대될 것으로 예측됩니다.

미국의 자가면역질환 진단(Autoimmune Disorders Diagnostics) 시장에 대해 조사 분석했으며, 시장 규모와 부문별 점유율, 시장 역학, 주요 동향, 경쟁 구도, 매출 예측, 주요 기업 등의 정보를 전해드립니다.

제1장 자가면역질환 진단의 개요

제2장 애널리스트의 견해

제3장 조사 방법

제4장 질환의 역학

제5장 세계의 자가면역질환 진단 시장 개요

제6장 미국의 자가면역질환 진단 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 표적 질환별
    • 검사별
    • 기술별
    • 지역별

제7장 미국의 항핵항체 검사 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 종류별

제8장 시장 역학

  • 성장 촉진요인
  • 과제

제9장 시장 동향과 발전

  • 바이오마커의 이용 증가
  • 연구소의 자동화
  • 랩온칩(Lab-on-Chip) 기기
  • 휴대용 진단 장비
  • 의사와 진단 연구소의 제휴

제10장 정책과 규제 상황

제11장 미국의 경제 개요

제12장 경쟁 구도

  • 경쟁 벤치마크
  • 기업 개요
    • Bio-Rad Laboratories, Inc.
    • Roche Diagnostics Corporation
    • Abbott Laboratories
    • Danaher Corporation
    • Siemens Healthcare Diagnostics, Inc.
    • Biomeriux Clinical Diagnostics
    • Immco Diagnostics
    • Beckton Dickson
    • Alere Inc.
    • Inova Diagnostics, Inc.

제13장 전략적 제안

도표

KSM 16.01.07

Autoimmune disorders occur when a person's immune system attacks his/her own body; and for detecting these disorders and prescribing required treatments, various laboratory tests are performed. Increasing healthcare expenditure, rapidly rising demand for autoimmune disease diagnostics and various ongoing technological advancements leading to the advent of innovative diagnostic procedures are some of the major factors anticipated to drive the United States autoimmune disorders diagnostics market over the next five years. Furthermore, growing disease burden of various autoimmune disorders, especially Rheumatoid Arthritis, Type 1 Diabetes, Multiple Sclerosis, Systemic Lupus Erythematosus (SLE), Inflammatory Bowel Disease (IBD), Psoriasis and Autoimmune Thyroiditis, is expected to boost the US autoimmune disorders diagnostics market through 2020.

According to Pharmaion report, "United States Autoimmune Disorders Diagnostics Market Opportunities, 2020", the autoimmune disorders diagnostics market in the United States is anticipated to cross US$ 6 billion by 2020. On the basis of target disease, the market is broadly segmented into two categories, namely, systemic autoimmune disorders diagnostics and localized autoimmune disorders diagnostics. Among these two categories, systemic autoimmune disorders diagnostics segment dominated the United States autoimmune disorders diagnostics market in 2014. The segment is anticipated to continue its dominance through 2020 on account of increasing ongoing research activities that are focussed on developing tests and technologies that would precisely detect the abnormalities in the organ functioning and thus deliver faster diagnosis. The largest market share in the United States autoimmune disorders diagnostics market was captured by the South-East region, followed by the Midwest, North-East, West and South-West regions. Some of the major players operating in United States autoimmune disorders diagnostics market include Bio-Rad Laboratories, Inc., Roche Diagnostics Corporation, Abbott Laboratories, Danaher Corporation and Siemens Healthcare Diagnostics, Inc., among others. "United States Autoimmune Disorders Diagnostics Market Opportunities, 2020" discusses the following aspects related to United States autoimmune disorders diagnostics market:

  • United States Autoimmune Disorders Diagnostics Market Size, Share & Forecast
  • Segmental Analysis - By Target Disease, By Test, By Technology & By Region
  • Policy & Regulatory Landscape
  • Changing Market Trends & Emerging Opportunities
  • Competitive Landscape & Strategic Recommendations

Why You Should Buy This Report?

  • To identify the on-going trends and anticipated growth in the next five years
  • To gain competitive knowledge of leading market players
  • To avail 10% customization in the report without any extra charges and get the research data or trends added in the report as per the buyer's specific needs

Report Methodology

The information contained in this report is based upon both primary and secondary sources. Primary research included interviews with diagnostics device manufacturers and industry experts. Secondary research included an exhaustive search of relevant publications like company annual reports, financial reports and other proprietary databases.

Table of Contents

1. Autoimmune Disorders Diagnostics Overview

2. Analyst View

3. Research Methodology

4. Disease Epidemiology

5. Global Autoimmune Disorders Diagnostics Market Overview

6. United States Autoimmune Disorders Diagnostics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Target Disease (Systemic Autoimmune Disorders Diagnostics & Localized Autoimmune Disorders Diagnostics)
    • 6.2.2. By Test (Urinalysis, Comprehensive Metabolic Panel, C-reactive Protein, Erythrocyte Sedimentation Rate, Complete Blood Count, Anti-Nuclear Antibody Test & Others)
    • 6.2.3. By Technology (Enzyme Immunoassay, Multiplexed Immunoassays, Immunofluorescence & Others)
    • 6.2.4. By Region (South-West, West, North-East, Midwest, South-East)

7. United States Anti-Nuclear Antibody Test Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type {Others (Anti-centromere Antibodies, Histone Antibody & Nucleolar Antibody), Anti-dsDNA Test & Extractable Nuclear Antigen (ENA) Panel}

8. Market Dynamics

  • 8.1. Drivers
  • 8.2. Challenges

9. Market Trends & Developments

  • 9.1. Increasing Use of Biomarkers
  • 9.2. Lab automation
  • 9.3. Lab-on-Chip Devices
  • 9.4. Portable Diagnostics Equipment
  • 9.5. Partnership with Physician and Diagnostics Laboratories

10. Policy & Regulatory Landscape

11. United States Economic Profile

12. Competitive Landscape

  • 12.1. Competition Benchmarking (Market Attractiveness)
  • 12.2. Company Profiles
    • 12.2.1. Bio-Rad Laboratories, Inc.
    • 12.2.2. Roche Diagnostics Corporation
    • 12.2.3. Abbott Laboratories
    • 12.2.4. Danaher Corporation
    • 12.2.5. Siemens Healthcare Diagnostics, Inc.
    • 12.2.6. Biomeriux Clinical Diagnostics
    • 12.2.7. Immco Diagnostics
    • 12.2.8. Beckton Dickson
    • 12.2.9. Alere Inc.
    • 12.2.10. Inova Diagnostics, Inc.

13. Strategic Recommendations

List of Figures

  • Figure 1: United States Autoimmune Disorders Prevalence per 100,000 Population, 2013
  • Figure 2: United States Autoimmune Disorders Diagnostics Market Size, By Value, 2010-2020F (USD Billion)
  • Figure 3: United States Autoimmune Disorders Diagnostics Market Share, By Target Disorder, By Value, 2010-2020F
  • Figure 4: United States Autoimmune Disorders Diagnostics Market, By Test, By Value, 2010-2020F
  • Figure 5: United States Autoimmune Disorders Diagnostics Market Share, By Technology, By Value, 2010-2020F
  • Figure 6: United States Autoimmune Disorders Diagnostics Market Share, By Region, By Value, 2014 & 2020F
  • Figure 7: United States Autoimmune Disorders Diagnostics Market Share, By Region, By Value, 2010-2020F
  • Figure 8: United States Anti-Nuclear Antibody Test Market Size, By Value, 2010-2020F (USD Billion)
  • Figure 9: United States Anti-Nuclear Antibody Test Market Share, By Type, By Value, 2010-2020F
  • Figure 10: United States Autoimmune Disease Prevalence, 2013 (Million)

List of Tables

  • Table 1: United States Average Annual Cost of Diagnosis and Treatment of Autoimmune Disorders, 2014
  • Table 2: United States Occurrence of Autoimmune Disorders in Males and Females
  • Table 3: Partial List of Autoimmune Diseases
  • Table 4: Conditions Associated with Positive Antinuclear Antibody (ANA) Test
  • Table 5: United States Research Funding for Autoimmune Disorder, By Year, (USD Million)
  • Table 6: List of Partners of Accelerating Medicine Partnership
Back to Top
전화 문의
F A Q